Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues

Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues

Item
http://www.wikidata.org/entity/Q28214483
Q28181744
sameAs
Kallikreins as biomarkers for prostate cancerThe emerging roles of human tissue kallikreins in cancerHuman tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progressionThe kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.Protein-binding microarray analysis of tumor suppressor AP2α target gene specificity.Systems analysis of the prostate tumor suppressor NKX3.1 supports roles in DNA repair and luminal cell differentiation.Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesionsThe tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.Cellular distribution of human tissue kallikreins: immunohistochemical localization.Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical ApplicationKLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone.α2 Integrin-Dependent Suppression of Pancreatic Adenocarcinoma Cell Invasion Involves Ectodomain Regulation of Kallikrein-Related Peptidase-5.Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.Quantified KLK15 gene expression levels discriminate prostate cancer from benign tumors and constitute a novel independent predictor of disease progression.
P2860

Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues

Item
http://www.wikidata.org/entity/Q28214483
description
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Mai 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: May 2002)
@en
vedecký článok (publikovaný 2002/05/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/05/01)
@nl
наукова стаття, опублікована в травні 2002
@uk
مقالة علمية (نشرت في مايو 2002)
@ar
name
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
@ast
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
@en
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
@nl
type
label
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
@ast
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
@en
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
@nl
prefLabel
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
@ast
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
@en
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698